Circulating desmosine as a biomarker of azithromycin treatment response

a post hoc analysis of the COLUMBUS randomised controlled trial

James D Chalmers (Lead / Corresponding author), Remco S Djamin, Marjolijn Schouten, Holly R Keir, Brendan Tan, Joachim G J V Aerts, Jeffrey T-J Huang, Menno van der Eerden

Research output: Contribution to journalArticle

48 Downloads (Pure)

Abstract

Circulating desmosine is not reduced by treatment with azithromycin in COPD but elevated desmosine may identify a patient group with a greater treatment response http://ow.ly/vN6N30mhBA1.

Original languageEnglish
Pages (from-to)1-4
Number of pages4
JournalERJ Open Research
Volume4
Issue number4
DOIs
Publication statusPublished - Oct 2018

Fingerprint

Desmosine
Azithromycin
Randomized Controlled Trials
Biomarkers
Chronic Obstructive Pulmonary Disease
Therapeutics

Cite this

Chalmers, James D ; Djamin, Remco S ; Schouten, Marjolijn ; Keir, Holly R ; Tan, Brendan ; Aerts, Joachim G J V ; Huang, Jeffrey T-J ; van der Eerden, Menno. / Circulating desmosine as a biomarker of azithromycin treatment response : a post hoc analysis of the COLUMBUS randomised controlled trial. In: ERJ Open Research. 2018 ; Vol. 4, No. 4. pp. 1-4.
@article{a46639a039714e21b3f6ecaf5d5b64cd,
title = "Circulating desmosine as a biomarker of azithromycin treatment response: a post hoc analysis of the COLUMBUS randomised controlled trial",
abstract = "Circulating desmosine is not reduced by treatment with azithromycin in COPD but elevated desmosine may identify a patient group with a greater treatment response http://ow.ly/vN6N30mhBA1.",
author = "Chalmers, {James D} and Djamin, {Remco S} and Marjolijn Schouten and Keir, {Holly R} and Brendan Tan and Aerts, {Joachim G J V} and Huang, {Jeffrey T-J} and {van der Eerden}, Menno",
note = "British Lung Foundation GSK/BLF Chair of Respiratory Research",
year = "2018",
month = "10",
doi = "10.1183/23120541.00136-2018",
language = "English",
volume = "4",
pages = "1--4",
journal = "ERJ Open Research",
issn = "2312-0541",
publisher = "European Respiratory Society",
number = "4",

}

Circulating desmosine as a biomarker of azithromycin treatment response : a post hoc analysis of the COLUMBUS randomised controlled trial. / Chalmers, James D (Lead / Corresponding author); Djamin, Remco S; Schouten, Marjolijn; Keir, Holly R; Tan, Brendan; Aerts, Joachim G J V; Huang, Jeffrey T-J; van der Eerden, Menno.

In: ERJ Open Research, Vol. 4, No. 4, 10.2018, p. 1-4.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Circulating desmosine as a biomarker of azithromycin treatment response

T2 - a post hoc analysis of the COLUMBUS randomised controlled trial

AU - Chalmers, James D

AU - Djamin, Remco S

AU - Schouten, Marjolijn

AU - Keir, Holly R

AU - Tan, Brendan

AU - Aerts, Joachim G J V

AU - Huang, Jeffrey T-J

AU - van der Eerden, Menno

N1 - British Lung Foundation GSK/BLF Chair of Respiratory Research

PY - 2018/10

Y1 - 2018/10

N2 - Circulating desmosine is not reduced by treatment with azithromycin in COPD but elevated desmosine may identify a patient group with a greater treatment response http://ow.ly/vN6N30mhBA1.

AB - Circulating desmosine is not reduced by treatment with azithromycin in COPD but elevated desmosine may identify a patient group with a greater treatment response http://ow.ly/vN6N30mhBA1.

U2 - 10.1183/23120541.00136-2018

DO - 10.1183/23120541.00136-2018

M3 - Article

VL - 4

SP - 1

EP - 4

JO - ERJ Open Research

JF - ERJ Open Research

SN - 2312-0541

IS - 4

ER -